Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
about
Nanoformulations of Rilpivirine for Topical Pericoital and Systemic Coitus-Independent Administration Efficiently Prevent HIV TransmissionTriple combination MPT vaginal microbicide using curcumin and efavirenz loaded lactoferrin nanoparticlesA review of nanotechnological approaches for the prophylaxis of HIV/AIDS.Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.Expression and localization of p-glycoprotein, multidrug resistance protein 4, and breast cancer resistance protein in the female lower genital tract of human and pigtailed macaque.Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV preventionGene Expression Profiling of Human Vaginal Cells In Vitro Discriminates Compounds with Pro-Inflammatory and Mucosa-Altering Properties: Novel Biomarkers for Preclinical Testing of HIV Microbicide Candidates.Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis.Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.Dissimilarities in the metabolism of antiretroviral drugs used in HIV pre-exposure prophylaxis in colon and vagina tissues.Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research.Osmotic pump tablets for delivery of antiretrovirals to the vaginal mucosa.Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation propertiesExpression, regulation, and function of drug transporters in cervicovaginal tissues of a mouse model used for microbicide testing.G2-S16 dendrimer as a candidate for a microbicide to prevent HIV-1 infection in women.Design and in vitro evaluation of tenofovir-loaded vaginal gels for the prevention of HIV infections.Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.Triple combination of carbosilane dendrimers, tenofovir and maraviroc as potential microbicide to prevent HIV-1 sexual transmission.Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice.Physiologically-based pharmacokinetic model of vaginally administered dapivirine ring and film formulations
P2860
Q27318354-0BB5787F-5249-4D34-8E23-D8F5F3B557BFQ28393885-16319794-4F67-4293-90B9-3F1E5DFDE0C6Q30431343-56E9F95C-3ECD-4E57-BC72-F38C227884C4Q33598736-16FF35C5-4BF7-4AD5-8E96-BB74347C91C8Q33821090-924FB55E-E37C-4EE1-9C95-3C1024D283FDQ34420654-A2D69EEB-79B1-48CA-A7AE-9E5565361E1FQ35002085-6543FBFF-F74F-459A-B033-B2BCF61FF19CQ35656128-EFBE1340-C02B-4527-81B2-CBAD54F05605Q36442232-C8E4A459-E57C-4FB3-AF32-F0F196374C31Q37023114-687336A9-5D3F-402B-9F85-0DCE4B50E35BQ37253552-707C9270-57E5-437D-B244-194697ABC882Q37258318-8A44CE64-B715-43E2-9471-DF5AF2B48048Q37583893-D58FD9B1-FCC8-4AF4-B528-638F8B6003C9Q37597118-C7D21AF8-F124-43F5-9461-FAF2B1BFE017Q37716218-FA48D32E-C1A0-4655-A9B5-AC05AB9D0496Q40135804-9993825A-1709-4721-8905-18BC7462453BQ40201612-EE4D6B59-C785-47F2-BFE2-9E39159EB028Q41051936-2EB2CF41-6E09-46C6-9999-AA24FCD09A49Q41339468-91328661-0255-4244-82C3-00A7481A55A2Q51166879-1544EE39-B513-4652-B97B-270BCE53DB6DQ58736449-77DA0398-4913-4BC3-8E55-73A9B75B8D13
P2860
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@ast
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@en
type
label
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@ast
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@en
prefLabel
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@ast
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@en
P2860
P1476
Formulation, pharmacokinetics and pharmacodynamics of topical microbicides.
@en
P2093
Angela D M Kashuba
Jessica L Adams
P2860
P304
P356
10.1016/J.BPOBGYN.2012.01.004
P577
2012-02-04T00:00:00Z